2027 Best Value Clinical and Industrial Drug Development Schools
[Clinical and Industrial Drug Development](/majors/health-care-professions/pharmacy-pharmaceutical-sciences/clinical-and-industrial-drug-development/) is a field worth comparing on the balance of cost and outcomes. The best values balance affordable tuition against strong post-graduation earnings.
To produce this 2027 ranking, College Factual evaluated 13 schools on the balance of cost and outcomes for clinical and industrial drug development students.
What’s on this page:
Finding the Best Value Clinical and Industrial Drug Development School for You
The clinical and industrial drug development program you select can have a big impact on your finances and your future. That is why we built our Best Value Clinical and Industrial Drug Development Schools ranking. It weighs the cost of a degree against the outcomes graduates go on to achieve, so you can find the strongest return on your investment.
See how we build our rankings
Customizing Your List
Since the program you select can have a significant impact on your future, we offer several rankings, including this Best Value Clinical and Industrial Drug Development Schools list, to help you choose. More interested in schools in a specific area of the country? Filter this list by region or state.
Want to compare schools head to head? Try our College Combat tool to weigh the factors that matter most to you.
Learn more about our methodology
2027 Best Value Clinical and Industrial Drug Development Schools in the United States
Below are the schools that deliver the strongest value in clinical and industrial drug development, balancing cost against outcomes.
Best Value Clinical and Industrial Drug Development Schools
Leading the list is University Of California San Diego, our #1 best value for clinical and industrial drug development in the United States. Located in the city of La Jolla, University Of California San Diego is a very large public university. In-state tuition and fees average $15,788, with out-of-state students paying around $47,676. Typical student debt for clinical and industrial drug development graduates is $17,101. Soon after graduation, clinical and industrial drug development degree recipients from University Of California San Diego generally make around $113,226. Weighed against typical debt, the earnings make a compelling case for value. The acceptance rate is 27%.
Students looking for strong value in clinical and industrial drug development will find it at Ivy Tech Community College, which ranked #2. Set in the city of Indianapolis, Ivy Tech Community College is a very large public institution. Expect in-state tuition and fees of around $5,154, while out-of-state students pay about $9,935. Students borrow a median of $11,889 to complete the clinical and industrial drug development program here. Early-career clinical and industrial drug development graduates make about $40,734. Set against $11,889 in median debt, that is a healthy payoff.
A rank of #3 makes John Tyler Community College one of the best values for clinical and industrial drug development. Set in the suburb of Chester, John Tyler Community College is a large public institution. Students from in state pay about $5,082 in tuition and fees, compared with $11,520 for out-of-state students. Students borrow a median of $11,262 to complete the clinical and industrial drug development program here. Clinical And Industrial Drug Development graduates of John Tyler Community College earn a median of $36,623 early in their careers. Weighed against typical debt, the earnings make a compelling case for value.
The strong cost-to-outcome balance at University Of Georgia earned it the #4 place for clinical and industrial drug development. University Of Georgia is a very large public school located in the city of Athens. The average in-state cost of tuition and fees is $11,450, with out-of-state students paying around $31,688. Typical student debt for clinical and industrial drug development graduates is $23,761. Clinical And Industrial Drug Development graduates of University Of Georgia earn a median of $114,226 early in their careers. That is a strong return on a $23,761 median debt. Roughly 38% of applicants are accepted.
University Of Washington Seattle Campus is a great value for students pursuing a degree in clinical and industrial drug development, landing the #5 spot this year. University Of Washington Seattle Campus is a very large public school located in the city of Seattle. Expect in-state tuition and fees of around $12,973, with out-of-state students paying around $43,209. Clinical And Industrial Drug Development graduates carry a median of $16,481 in student loans. Early-career clinical and industrial drug development graduates make about $109,852. Set against $16,481 in median debt, that is a healthy payoff. The acceptance rate is 39%.
University Of Rhode Island earned the #6 position for value in clinical and industrial drug development this year. Located in the suburb of Kingston, University Of Rhode Island is a very large public university. Expect in-state tuition and fees of around $16,942, compared with $37,146 for out-of-state students. Typical student debt for clinical and industrial drug development graduates is $23,432. Early-career clinical and industrial drug development graduates make about $52,821. Weighed against typical debt, the earnings make a compelling case for value. The acceptance rate is 72%.
Campbell University landed the #7 spot for clinical and industrial drug development value this year. Located in the town of Buies Creek, Campbell University is a moderately-sized private not-for-profit university. The average in-state cost of tuition and fees is $41,600. Students borrow a median of $23,065 to complete the clinical and industrial drug development program here. Soon after graduation, clinical and industrial drug development degree recipients from Campbell University generally make around $77,265. That is a strong return on a $23,065 median debt. Campbell University admits about 87% of applicants.
University Of Cincinnati Main Campus landed the #8 spot for clinical and industrial drug development value this year. Set in the city of Cincinnati, University Of Cincinnati Main Campus is a very large public institution. Students from in state pay about $13,363 in tuition and fees, compared with $28,697 for out-of-state students. Typical student debt for clinical and industrial drug development graduates is $23,530. Early-career clinical and industrial drug development graduates make about $103,717. Set against $23,530 in median debt, that is a healthy payoff. The acceptance rate is 85%.
Temple University earned the #9 position for value in clinical and industrial drug development this year. Located in the city of Philadelphia, Temple University is a very large public university. Expect in-state tuition and fees of around $23,005, with out-of-state students paying around $38,805. Students borrow a median of $26,259 to complete the clinical and industrial drug development program here. Soon after graduation, clinical and industrial drug development degree recipients from Temple University generally make around $111,896. Weighed against typical debt, the earnings make a compelling case for value. The acceptance rate is 80%.
Saint Josephs University placed #10 among the best values for clinical and industrial drug development. Located in the city of Philadelphia, Saint Josephs University is a moderately-sized private not-for-profit university. In-state tuition and fees average $53,260. Students borrow a median of $26,426 to complete the clinical and industrial drug development program here. Clinical And Industrial Drug Development graduates of Saint Josephs University earn a median of $88,125 early in their careers. Set against $26,426 in median debt, that is a healthy payoff. Roughly 89% of applicants are accepted.
University Of Southern California came in at #11 for value in clinical and industrial drug development this year. University Of Southern California is a very large private not-for-profit school located in the city of Los Angeles. Students from in state pay about $71,647 in tuition and fees. Typical student debt for clinical and industrial drug development graduates is $15,625. Early-career clinical and industrial drug development graduates make about $114,101. That is a strong return on a $15,625 median debt. University Of Southern California admits about 10% of applicants.
Massachusetts College Of Pharmacy And Health Sciences landed the #12 spot for clinical and industrial drug development value this year. Located in the city of Boston, Massachusetts College Of Pharmacy And Health Sciences is a moderately-sized private not-for-profit university. In-state tuition and fees average $40,530. Typical student debt for clinical and industrial drug development graduates is $27,000. Clinical And Industrial Drug Development graduates of Massachusetts College Of Pharmacy And Health Sciences earn a median of $78,861 early in their careers. That is a strong return on a $27,000 median debt. The acceptance rate is 85%.
Stevens Institute Of Technology came in at #13 for value in clinical and industrial drug development this year. Located in the suburb of Hoboken, Stevens Institute Of Technology is a moderately-sized private not-for-profit university. Students from in state pay about $63,462 in tuition and fees. Clinical And Industrial Drug Development graduates carry a median of $26,767 in student loans. Clinical And Industrial Drug Development graduates of Stevens Institute Of Technology earn a median of $87,055 early in their careers. That is a strong return on a $26,767 median debt. Roughly 48% of applicants are accepted.
Narrow Clinical and Industrial Drug Development Schools by Region
View All Rankings >
Clinical and Industrial Drug Development is one of many programs to choose from within the area of study. Browse the parent area of study.
Notes and References
This list is compiled by College Factual (MF_RANKING_2025), 2027 edition. Schools are scored on the balance of cost (tuition and student debt) against student outcomes (post-graduation earnings) — a measure of return on investment, drawn primarily from the U.S. Department of Education (IPEDS and College Scorecard).
Ranking method: College Major Best Value · 13 schools evaluated.
*Averages shown above reflect the top 13 ranked schools only.
- The Integrated Postsecondary Education Data System (IPEDS) from the National Center for Education Statistics (NCES), a branch of the U.S. Department of Education (DOE), serves as the core of our data about colleges.
- Some other college data, including much of the graduate earnings data, comes from the U.S. Department of Education’s (College Scorecard).
More about our data sources and methodologies.
